✦ LIBER ✦

298 - Antibody therapy of lympold malignancies: Experience with CD52 (CAMPATH-1) antibodies

✍ Scribed by M.J.S. Dyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of CLL with humanized CD52 antib

✍ Håkan Mellstedt; Jeanette Lundin; Herman Waldman; Geoff Hale; Anders Österborg 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Campath-1H (anti-CD52) monoclonal antibo

✍ G. A. Pangalis; M. N. Dimopoulou; M. K. Angelopoulou; Ch. Tsekouras; T. P. Vassi 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 87 KB

Recognition of CD52 allelic gene product

✍ C. HALE; M. BARTHOLOMEW; V. TAYLOR; J. STABLES; P. TOPLEY; Dr J. TITE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 866 KB

Impact on T-cell depletion and CD34+ cel

✍ Williams, R.J.; Clarke, E.; Blair, A.; Every, R.; Hale, G.; Waldmann, H.; Brooke 📂 Article 📅 2000 🏛 Informa plc 🌐 English ⚖ 77 KB

Therapy of steroid-refractory acute GVHD

✍ Schub, N; Günther, A; Schrauder, A; Claviez, A; Ehlert, C; Gramatzki, M; Repp, R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 340 KB

Cellular immune reconstitution after sub

✍ Lundin, J; Porwit-MacDonald, A; Rossmann, E D; Karlsson, C; Edman, P; Rezvany, M 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB